🇺🇸 FDA
Patent

US 12053520

Glycan-masked engineered outer domains of HIV-1 gp120 and their use

granted A61KA61K2039/5258A61K2039/55555

Quick answer

US patent 12053520 (Glycan-masked engineered outer domains of HIV-1 gp120 and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K2039/5258, A61K2039/55555, A61K39/21, A61K39/295